Pages that link to "Q34914587"
Jump to navigation
Jump to search
The following pages link to Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis (Q34914587):
Displaying 50 items.
- Multiple advantageous amino acid variants in the NAT2 gene in human populations (Q21144240) (← links)
- Worldwide distribution of NAT2 diversity: implications for NAT2 evolutionary history (Q21283781) (← links)
- N-acetyltransferase 2 genotypes are associated with diisocyanate-induced asthma (Q23910398) (← links)
- Genetic susceptibility to occupational exposures (Q23911384) (← links)
- Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes (Q24540724) (← links)
- A case-only analysis of the interaction between N-acetyltransferase 2 haplotypes and tobacco smoke in breast cancer etiology. (Q24810267) (← links)
- Inferring haplotypes at the NAT2 locus: the computational approach (Q24815593) (← links)
- Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery (Q26995125) (← links)
- Polymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancers (Q27010137) (← links)
- Structural and Biochemical Characterization of an Active Arylamine N-Acetyltransferase Possessing a Non-canonical Cys-His-Glu Catalytic Triad (Q27678621) (← links)
- Insight into cofactor recognition in arylamine N-acetyltransferase enzymes: structure of Mesorhizobium loti arylamine N-acetyltransferase in complex with coenzyme A (Q27697952) (← links)
- Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses (Q28072392) (← links)
- N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk (Q28388128) (← links)
- Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines (Q28391158) (← links)
- RNAi-mediated knock-down of arylamine N-acetyltransferase-1 expression induces E-cadherin up-regulation and cell-cell contact growth inhibition (Q28477123) (← links)
- Effects of single nucleotide polymorphisms on human N-acetyltransferase 2 structure and dynamics by molecular dynamics simulation (Q28477297) (← links)
- 4,4'-methylenedianiline-induced hepatotoxicity is modified by N-acetyltransferase 2 (NAT2) acetylator polymorphism in the rat (Q28568438) (← links)
- Arylamine N-acetyltransferase 2 expression in the developing heart (Q28587286) (← links)
- Fire Usage and Ancient Hominin Detoxification Genes: Protective Ancestral Variants Dominate While Additional Derived Risk Variants Appear in Modern Humans (Q28595433) (← links)
- Rapid birth-and-death evolution of the xenobiotic metabolizing NAT gene family in vertebrates with evidence of adaptive selection (Q28709654) (← links)
- Analysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversity (Q28744372) (← links)
- Identification of cancer chemopreventive isothiocyanates as direct inhibitors of the arylamine N-acetyltransferase-dependent acetylation and bioactivation of aromatic amine carcinogens (Q28829316) (← links)
- 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats (Q29347040) (← links)
- Effect of thermal treatment on meat proteins with special reference to heterocyclic aromatic amines (HAAs). (Q30363447) (← links)
- Artificial targeting of misfolded cytosolic proteins to endoplasmic reticulum as a mechanism for clearance (Q30657635) (← links)
- Interspecies metabolism of heterocyclic aromatic amines and the uncertainties in extrapolation of animal toxicity data for human risk assessment (Q30979183) (← links)
- Interrogating differences in expression of targeted gene sets to predict breast cancer outcome (Q31122465) (← links)
- Kinetic characterisation of arylamine N-acetyltransferase from Pseudomonas aeruginosa (Q33279454) (← links)
- Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma (Q33286211) (← links)
- Probing the catalytic potential of the hamster arylamine N-acetyltransferase 2 catalytic triad by site-directed mutagenesis of the proximal conserved residue, Tyr190. (Q33587691) (← links)
- Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis (Q33601705) (← links)
- Dose-dependent reduction of 3,2'-dimethyl-4-aminobiphenyl-derived DNA adducts in colon and liver of rats administered celecoxib (Q33613090) (← links)
- Effect of rapid human N-acetyltransferase 2 haplotype on DNA damage and mutagenesis induced by 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline (MeIQx). (Q33646913) (← links)
- N-acetyltransferase 2 activity and folate levels (Q33689052) (← links)
- Interethnic diversity of NAT2 polymorphisms in Brazilian admixed populations. (Q33710997) (← links)
- Well-done meat consumption, NAT1 and NAT2 acetylator genotypes and prostate cancer risk: the multiethnic cohort study (Q33981646) (← links)
- Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background (Q34125066) (← links)
- Absence of association between N-acetyltransferase 2 acetylator status and colorectal cancer susceptibility: based on evidence from 40 studies (Q34189473) (← links)
- Inflammatory cytokines suppress arylamine N-acetyltransferase 1 in cholangiocarcinoma cells (Q34225242) (← links)
- Genetic polymorphisms in cytochrome P450s, GSTs, NATs, alcohol consumption and risk of non-Hodgkin lymphoma (Q34247468) (← links)
- Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer (Q34311814) (← links)
- NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses (Q34603354) (← links)
- N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients (Q34944536) (← links)
- Human pharmacogenomic variations and their implications for antifungal efficacy (Q35070838) (← links)
- Pharmacogenomics of Drugs Affecting the Cardiovascular System (Q35127795) (← links)
- Cytochrome P4501A2 phenotype and bladder cancer risk: The Shanghai bladder cancer study (Q35199390) (← links)
- Genetic susceptibility to bladder cancer risk and outcome. (Q35212792) (← links)
- NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study (Q35233775) (← links)
- Toxicological assessment of noxious inhalants. (Q35427224) (← links)
- Hair dye use and risk of bladder cancer in the New England bladder cancer study (Q35464023) (← links)